SNDL Lowers Its Stake In Indiva To 8.57%
SNDL Inc. (NASDAQ: SNDL) announced that between June 10, 2023, and June 22, 2023, SNDL disposed of 3.3 million common shares in the capital of Indiva Limited (OTCQX: NDVAF)(TSXV:NDVA) .
Buddi Teams Up With springbig To Help Cannabis Retailers ‘Establish Strong Customer Relationships’
Clearleaf Inc, DBA "Buddi", a Vancouver-based Canadian technology company specializing in e-commerce and interactive digital menu software solutions, launched a loyalty integration with springbig (NASDAQ: SBIG) , a provider of SaaS-based marketing solutions.
TerrAscend To Secure $15M Via Private Placements
TerrAscend Corp. (OTCQX: TRSSF) (CSE:TER) announced its intention to complete two concurrent private placements for total gross proceeds of approximately $15 million. The company has received indicative orders of approximately $15 million.
Grown Rogue Q2 FY23 Revenue Grows 18.2%, What About Income?
Grown Rogue International Inc. (OTCPK:GRUSF) (CSE:GRIN) released its fiscal second quarter 2023 results for the three months ended April 30, 2023, revealing revenue of $6 million, an increase of 28% compared to $4.7 million in Q2 2022.
22nd Century To Secure $5.3M Via Registered Direct Offering Priced Above Market
22nd Century Group, Inc. (NASDAQ: XXII) has entered into definitive agreements with certain investors for the purchase and sale of 11.2 million shares of common stock and warrants at a price of $0.47 per share in a registered direct offering priced above market.
Court Upholds Class Action Lawsuit Against Jeeter Cannabis Over THC Content Dispute
Dovel & Luner law firm filed a class action suit in October against DreamFields Inc. and Med for America Inc., which make, sell and market the “Jeeter” brand of pre-rolls, on behalf of Jasper Centeno and Blake Wilson from California who purchased cannabis products with inaccurate THC content labels.
AWH To Secure $7M Via Private Placement
Ascend Wellness Holdings, Inc. (OTCQX: AAWH) (CSE:AAWH.U) announced that the company intends to complete a private placement offering, which will raise an aggregate of $7 million in equity financing.
Exclusive: Clearmind And SciSparc To Conduct Study Evaluating Psychedelics And CannAmide Based Drug For Treatment Of Obesity And Metabolic Syndrome
Clearmind Medicine Inc. (NASDAQ: CMND) (CSE:CMND) (FSE:CWY) announced that as part of the company's ongoing collaboration with SciSparc Ltd.